Advertisement · 728 × 90
#
Hashtag
#DULAGLUTIDE
Advertisement · 728 × 90
MultiSearch Tag Explorer MultiSearch Tag Explorer - Explore tags and search results by aéPiot - aéPiot: Independent SEMANTIC Web 4.0 Infrastructure (Est. 2009). High-density Functional Semantic Connectivity with 100/100 Trust...

#DULAGLUTIDE
advanced-search.aepiot.ro/advanced-sea...
headlines-world.com

0 0 0 0
Post image

#Dulaglutide Effect on #Proteins Associated With #CKD Progression

#VisualAbstract by Cristina Popa

www.kireports.org/article/S2468-0249(26)00...

3 1 0 0

Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
Basile, Jan et al.
Paper
Details
#Tirzepatide #Dulaglutide #Type2Diabetes

0 0 0 0

From #EASD2025 - #Tirzepatide is noninferior to #dulaglutide for protecting against cardiovascular events in people with type 2 diabetes and atherosclerotic cardiovascular disease.

👉 buff.ly/mzd96B5

#MedNews

0 0 1 0

A review of 48 clinical trials on GLP-1 safety suggests the popular meds probably have little to no effect on cancer risk.

youtu.be/tzKISp4ubqs

#GLP1 #Semaglutide #Tirzepatide #Dulaglutide #DiabetesCare #ObesityTreatment #CancerRisk #MedicalResearch #ClinicalTrials #HealthNews

0 0 0 0
Four graphs show cumulative incidence vs. year (0-4) for three drugs: dulaglutide (blue), liraglutide (orange), semaglutide (green). Graphs depict: A) kidney failure and death, B) cardiovascular and kidney events/death, C) major cardiovascular events/death, D) all-cause mortality.

Four graphs show cumulative incidence vs. year (0-4) for three drugs: dulaglutide (blue), liraglutide (orange), semaglutide (green). Graphs depict: A) kidney failure and death, B) cardiovascular and kidney events/death, C) major cardiovascular events/death, D) all-cause mortality.

In veterans with type 2 #diabetes without end-stage kidney disease, #liraglutide, #semaglutide, and #dulaglutide had similar risks for kidney and cardiovascular outcomes, though liraglutide was associated with lower mortality than dulaglutide.

ja.ma/4q7ZCzJ

0 0 0 0

I expect the #glp1ra online and in-real-life shaming and bullying to get worse after the publication of #SURPASS-CVOT #tirzepatide #dulaglutide.
I think my #gigablock game will surpass (pun intended) my peak of the early pandemic era esp after I have gone through the egfr data.

2 0 1 0

I expect the #glp1ra online and in-real-life shaming and bullying to get worse after the publication of #SURPASS-CVOT #tirzepatide #dulaglutide.
I think my #gigablock game will surpass (pun intended) my peak of the early pandemic era esp after I have gone through the egfr data.

6 0 2 0
Preview
Tirzepatide matches dulaglutide for cardioprotection in type 2 diabetes Tirzepatide is noninferior to dulaglutide for protecting against cardiovascular events in people with type 2 diabetes and atherosclerotic cardiovascular disease.

From #EASD2025 - #Tirzepatide is noninferior to #dulaglutide for protecting against cardiovascular events in people with type 2 #diabetes and atherosclerotic cardiovascular disease.

Full story 👉 buff.ly/dlX26Xw

#MedNews

1 1 0 0
Post image

🚨Day 3 highlights from #EASD2025:

first results from #SURPASS #CVOT (#tirzepatide vs #dulaglutide), new data on #CGM in pregnancy (#T1D, #T2D & #GDM), plus advice from Prof. Miriam Cnop on building successful labs.

Watch now 👉 easd-elearning.eu/news/455/EAS...

3 1 0 0
Preview
Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart dise... The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

Lilly SURPASS-CVOT study result 🫀
Mounjaro not inferior to Trulicity

Primary endpoint:
Risk of cardiovascular death, heart attack, or stroke 8% lower for Mounjaro than Trulicity, but p = 0.086 📊

investor.lilly.com/news-release...

#Tirzepatide #Dulaglutide #Mounjaro #Trulicity #$LLY #NCT04255433

1 1 0 0
Original post on tenforward.social

#Tirzepatide ad in the theater: one of the possible side effects listed as "inflamed pancreas." That feels like a scummy way to avoid saying #pancreatitis. It's no fun. But it's a rare side-effect at least. I'm on #dulaglutide which also has that as a rare side-effect. But I had already […]

1 0 1 0
ACP Journals

Switching to #Tirzepatide bests staying on #Dulaglutide in patients with in inadequately controlled type 2 diabetes according to a randomized trial just published in the Annals of Internal Medicine www.acpjournals.org/doi/10.7326/...

0 0 0 0
Preview
Tirzepatide vs. Traditional Diabetes Medications: Which Works Best? Diabetes, particularly type 2 diabetes, has become a global health crisis, affecting millions of people worldwide. For those managing the…

Learn how #Tirzepatide differs from traditional #diabetes #medications, such as #Metformin, 3Insulin, and other GLP-1 receptor agonists like #Semaglutide, #Liraglutide, and #Dulaglutide. medium.com/@mrmedoffici...

1 1 0 0
Post image

Adding sCT (amylin receptor agonist) to an ongoing #dulaglutide treatment reduces alcohol intake in male and female rats.

However, the simultaneous administration of sCT and dulaglutide initially reduces alcohol intake but is followed by tolerance.

1 0 1 0